Undifferentiated Carcinoma of the Liver with Neuroendocrine Features

A Case Report

Hidekazu Nakasuka, Shuichi Okada, Takuji Okusaka, Hiroshi Ishii, Masahumi Ikeda, Ryoji Ito, Hiroki Kosakamoto, Masayoshi Yoshimori, Yukihiro Nakanishi, Michiie Sakamoto

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Undifferentiated carcinoma of the liver is very rare. A 54-year-old man was admitted to our hospital for a detailed examination of multiple liver tumors. These tumors were high or low echoic on ultrasonography, but not enhanced by contrast medium in dynamic computed tomography. A fine-needle aspiration biopsy specimen of the tumor showed undifferentiated carcinoma. The serum level of neuron-specific enolase was high (357 ng/ml) and the immunohistochemical stain of the biopsy specimen was positive for synaptophysin. We diagnosed the patient as having undifferentiated carcinoma of the liver with neuroendocrine features. The patient was treated with combined systemic chemotherapy: etoposide 100 mg/m2/day for three days plus cisplatin 80 mg/m2/day on day one. He achieved a partial response, the duration of which was 7+ months. The serum neuron-specific enolase levels were decreased to the normal range after chemotherapy. Primary liver carcinoma with neuroendocrine features is extremely rare, but in a suspicious case it is important to measure the serum levels of neuroendocrine markers and make a histological confirmation, because chemotherapy may be effective for this disease.

Original languageEnglish
Pages (from-to)401-404
Number of pages4
JournalJapanese Journal of Clinical Oncology
Volume28
Issue number6
Publication statusPublished - 1998
Externally publishedYes

Fingerprint

Carcinoma
Phosphopyruvate Hydratase
Liver
Drug Therapy
Serum
Neuroendocrine Carcinoma
Neoplasms
Synaptophysin
Etoposide
Fine Needle Biopsy
Contrast Media
Cisplatin
Ultrasonography
Reference Values
Coloring Agents
Tomography
Biopsy

Keywords

  • Liver cancer
  • Neuroendocrine marker
  • Neuron-specific enolase
  • PVP therapy
  • Undifferentiated carcinoma

ASJC Scopus subject areas

  • Oncology

Cite this

Nakasuka, H., Okada, S., Okusaka, T., Ishii, H., Ikeda, M., Ito, R., ... Sakamoto, M. (1998). Undifferentiated Carcinoma of the Liver with Neuroendocrine Features: A Case Report. Japanese Journal of Clinical Oncology, 28(6), 401-404.

Undifferentiated Carcinoma of the Liver with Neuroendocrine Features : A Case Report. / Nakasuka, Hidekazu; Okada, Shuichi; Okusaka, Takuji; Ishii, Hiroshi; Ikeda, Masahumi; Ito, Ryoji; Kosakamoto, Hiroki; Yoshimori, Masayoshi; Nakanishi, Yukihiro; Sakamoto, Michiie.

In: Japanese Journal of Clinical Oncology, Vol. 28, No. 6, 1998, p. 401-404.

Research output: Contribution to journalArticle

Nakasuka, H, Okada, S, Okusaka, T, Ishii, H, Ikeda, M, Ito, R, Kosakamoto, H, Yoshimori, M, Nakanishi, Y & Sakamoto, M 1998, 'Undifferentiated Carcinoma of the Liver with Neuroendocrine Features: A Case Report', Japanese Journal of Clinical Oncology, vol. 28, no. 6, pp. 401-404.
Nakasuka H, Okada S, Okusaka T, Ishii H, Ikeda M, Ito R et al. Undifferentiated Carcinoma of the Liver with Neuroendocrine Features: A Case Report. Japanese Journal of Clinical Oncology. 1998;28(6):401-404.
Nakasuka, Hidekazu ; Okada, Shuichi ; Okusaka, Takuji ; Ishii, Hiroshi ; Ikeda, Masahumi ; Ito, Ryoji ; Kosakamoto, Hiroki ; Yoshimori, Masayoshi ; Nakanishi, Yukihiro ; Sakamoto, Michiie. / Undifferentiated Carcinoma of the Liver with Neuroendocrine Features : A Case Report. In: Japanese Journal of Clinical Oncology. 1998 ; Vol. 28, No. 6. pp. 401-404.
@article{283282ea33c340fca0eb3d413f1736bd,
title = "Undifferentiated Carcinoma of the Liver with Neuroendocrine Features: A Case Report",
abstract = "Undifferentiated carcinoma of the liver is very rare. A 54-year-old man was admitted to our hospital for a detailed examination of multiple liver tumors. These tumors were high or low echoic on ultrasonography, but not enhanced by contrast medium in dynamic computed tomography. A fine-needle aspiration biopsy specimen of the tumor showed undifferentiated carcinoma. The serum level of neuron-specific enolase was high (357 ng/ml) and the immunohistochemical stain of the biopsy specimen was positive for synaptophysin. We diagnosed the patient as having undifferentiated carcinoma of the liver with neuroendocrine features. The patient was treated with combined systemic chemotherapy: etoposide 100 mg/m2/day for three days plus cisplatin 80 mg/m2/day on day one. He achieved a partial response, the duration of which was 7+ months. The serum neuron-specific enolase levels were decreased to the normal range after chemotherapy. Primary liver carcinoma with neuroendocrine features is extremely rare, but in a suspicious case it is important to measure the serum levels of neuroendocrine markers and make a histological confirmation, because chemotherapy may be effective for this disease.",
keywords = "Liver cancer, Neuroendocrine marker, Neuron-specific enolase, PVP therapy, Undifferentiated carcinoma",
author = "Hidekazu Nakasuka and Shuichi Okada and Takuji Okusaka and Hiroshi Ishii and Masahumi Ikeda and Ryoji Ito and Hiroki Kosakamoto and Masayoshi Yoshimori and Yukihiro Nakanishi and Michiie Sakamoto",
year = "1998",
language = "English",
volume = "28",
pages = "401--404",
journal = "Japanese Journal of Clinical Oncology",
issn = "0368-2811",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - Undifferentiated Carcinoma of the Liver with Neuroendocrine Features

T2 - A Case Report

AU - Nakasuka, Hidekazu

AU - Okada, Shuichi

AU - Okusaka, Takuji

AU - Ishii, Hiroshi

AU - Ikeda, Masahumi

AU - Ito, Ryoji

AU - Kosakamoto, Hiroki

AU - Yoshimori, Masayoshi

AU - Nakanishi, Yukihiro

AU - Sakamoto, Michiie

PY - 1998

Y1 - 1998

N2 - Undifferentiated carcinoma of the liver is very rare. A 54-year-old man was admitted to our hospital for a detailed examination of multiple liver tumors. These tumors were high or low echoic on ultrasonography, but not enhanced by contrast medium in dynamic computed tomography. A fine-needle aspiration biopsy specimen of the tumor showed undifferentiated carcinoma. The serum level of neuron-specific enolase was high (357 ng/ml) and the immunohistochemical stain of the biopsy specimen was positive for synaptophysin. We diagnosed the patient as having undifferentiated carcinoma of the liver with neuroendocrine features. The patient was treated with combined systemic chemotherapy: etoposide 100 mg/m2/day for three days plus cisplatin 80 mg/m2/day on day one. He achieved a partial response, the duration of which was 7+ months. The serum neuron-specific enolase levels were decreased to the normal range after chemotherapy. Primary liver carcinoma with neuroendocrine features is extremely rare, but in a suspicious case it is important to measure the serum levels of neuroendocrine markers and make a histological confirmation, because chemotherapy may be effective for this disease.

AB - Undifferentiated carcinoma of the liver is very rare. A 54-year-old man was admitted to our hospital for a detailed examination of multiple liver tumors. These tumors were high or low echoic on ultrasonography, but not enhanced by contrast medium in dynamic computed tomography. A fine-needle aspiration biopsy specimen of the tumor showed undifferentiated carcinoma. The serum level of neuron-specific enolase was high (357 ng/ml) and the immunohistochemical stain of the biopsy specimen was positive for synaptophysin. We diagnosed the patient as having undifferentiated carcinoma of the liver with neuroendocrine features. The patient was treated with combined systemic chemotherapy: etoposide 100 mg/m2/day for three days plus cisplatin 80 mg/m2/day on day one. He achieved a partial response, the duration of which was 7+ months. The serum neuron-specific enolase levels were decreased to the normal range after chemotherapy. Primary liver carcinoma with neuroendocrine features is extremely rare, but in a suspicious case it is important to measure the serum levels of neuroendocrine markers and make a histological confirmation, because chemotherapy may be effective for this disease.

KW - Liver cancer

KW - Neuroendocrine marker

KW - Neuron-specific enolase

KW - PVP therapy

KW - Undifferentiated carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0032088060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032088060&partnerID=8YFLogxK

M3 - Article

VL - 28

SP - 401

EP - 404

JO - Japanese Journal of Clinical Oncology

JF - Japanese Journal of Clinical Oncology

SN - 0368-2811

IS - 6

ER -